C12Y 305/01038
Glutamin-ase
Official title: Glutamin-(asparagin-)ase (3.5.1.38)
C12Y305/01038 (Glutamin-ase) appears on 5 US grants and 6 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 6
- Assignees
- 8
- Inventors
- 15
- Latest grant
- 17 Jan 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Recent patents
- Gene ANSB knockout mutant of citrobacter werkmanii and application thereof17 Jan 2023US 11,555,193 B1Institute of Microbiology, Guangdong Academy of Sciences (Guangdong Detection Center of Micr
- Processes of producing a fermentation product7 Feb 2017US 9,562,239 B2Novozymes North America, Inc.
- Processes of producing a fermentation product16 Jun 2015US 9,057,087 B2Novozymes North America, Inc.
- Method for producing therapeutically suitable glutaminase30 May 2006US 7,052,689 B2ME Medical Enzymes AG
- Genetically engineered glutaminase and its use in antiviral and anticancer therapy6 Nov 2001US 6,312,939 B1ME Medical Enzymes AG
- Processes of Producing a Fermentation Product27 Aug 2015US 2015/0240265 A1Novozymes North America, Inc.
- Processes of Producing a Fermentation Product12 Dec 2013US 2013/0330785 A1Novozymes A/S
- Pegylation of therapeutic agents19 Jun 2008US 2008/0145354 A1University of South Carolina
- Genetically engineered glutaminase and its use in antiviral and anticancer therapy26 Oct 2006US 2006/0240414 A1ME Medical Enzymes AG
- Genetically engineered glutaminase and its use in antiviral and anticancer therapy30 May 2002US 2002/0064862 A1ME Medical Enzymes AG
Most cited
By later US patents